Specimens for Lung Cancer Panel Design
ConditionLung Nodules
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMaverix Medical
About this trial
This is an observational study designed to determine the optimal combination of biomarkers and clinical data for the early detection, confirmation, and better treatment of lung cancer including minimizing recurrence.
Eligibility criteria
Qualifiers
The patient has at least one indeterminant nodule with a diameter greater than or equal to 5mm and a Mayo SPN risk greater than 5%, identified by radiology, that has not been biopsied or undergone surgery.
The patient and the treating physician intend to follow up on the nodule with a biopsy procedure, PET scan, or active surveillance, with the procedure or next surveillance planned within the next 7 months.
Ability to understand the study and sign an informed consent form
Relevant clinical data accessible
Disqualifiers
None
Trial design
Treatments tested in this trial
- Not listed
Trial groups
2,000 Participants
are grouped into 3 trial groupsLocations
1Maverix Medical85004, PhoenixArizona, United States
Sponsors and collaborators
Maverix Medical
Lead sponsor
Source ClinicalTrials.gov